Latest Breaking News On - University of california san franisco - Page 1 : comparemela.com

Biotech startup Ambagon Therapeutics is taking a new approach to making elusive protein targets “druggable” by using molecular glues. The biotech has a pipeline of preclinical cancer drugs and it has raised $85 million to support their development.

United statesMichelle arkinChristian ottmannNancy pryerScott clarkeLuc brunsveldA alpha bioEindhoven university of technologyUniversity of california san franiscoMission biocapitalVentures fundAmbagon therapeuticsMonte rosa therapeuticsSan carolosCalifornia san franiscoEindhoven university